share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

SEC announcement ·  Apr 1 13:36
Summary by Moomoo AI
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more